HKU Scholars Hub: Browsing DSpace

Browsing by Author Yurdaydin, C

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中

or enter first few letters:

Showing results 1 to 4 of 4

	Title	Author(s)	Issue Date
	Atherosclerotic cardiovascular disease risk profile of patients with chronic hepatitis B treated with tenofovir alafenamide or tenofovir disoproxil fumarate for 96 weeks Journal:Alimentary Pharmacology and Therapeutics	Fung, SK Pan, CQ Wong, GL Seto, WK Ahn, SH Chen, CY Hann, HL Jablkowski, MS Kim, YJ Yurdaydin, C Peng, CY Nguyen, T Yatsuhashi, H Flaherty, JF Yee, LJ Abramov, F Wang, H Abdurakhmanov, D Lim, YS Buti, M	31-Oct-2023
	Peginterferon alfa-2a alone, lamivudine alone, and the two in combination in patients with HBeAg-negative chronic hepatitis B Journal:New England Journal of Medicine	Marcellin, P Lau, GK Bonino, F Farci, P Hadziyannis, S Jin, R Lu, ZM Piratvisuth, T Germanidis, G Yurdaydin, C Diago, M Gurel, S Lai, MY Button, P Pluck, N	2004
	Predicting response to peginterferon α-2a, lamivudine and the two combined for HBeAg-negative chronic hepatitis B	Bonino, F Marcellin, P Lau, GKK Hadziyannis, S Jin, R Piratvisuth, T Germanidis, G Yurdaydin, C Diago, M Gurel, S Lai, MY Brunetto, MR Farci, P Popescu, M McCloud, P	2007
	The case for simplifying and using absolute targets for viral hepatitis elimination goals Journal:Journal of Viral Hepatitis	Razavi, H Blach, S Razavi-Shearer, D Abaalkhail, F Abbas, Z Abdallah, A Abrao Ferreira, P Abu Raddad, LJ Adda, D Agarwai, K Aghemo, A Ahmed, A Al‐Busafi, SA Al‐hamoudi, W Al‐Kaabi, S Al‐Romaihi, H Aljarallah, B AlNaamani, K Alqahtani, S Alswat, K Altraif, I Thein, H-H Thompson, P Tolmane, L Toy, M Valantinas, J Van de Vijver, D Vélez‐Möller, P Vince, A Waked, I Wang, S Wedemeyer, H Wong, V Xie, Q Yamada, S Yang, H-I Yesmembetov, K Yilmaz, Y Younossi, Z Yu, M-L Yuen, RMF Yurdaydin, C Yusuf, A Zekry, A Zeuzem, S	2021

Showing results 1 to 4 of 4